Achim Rittmeyer
8PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 06, 2026
Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population.Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich
|Jan 31, 2026
Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population.Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich
|May 30, 2025
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non-Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial.Enriqueta Felip, Nasser Altorki, Caicun Zhou
|Jun 19, 2024
Therapeutic Patterns and Clinical Outcomes in Limited Disease Small Cell Lung Cancer: A Decade of Analysis at a Tertiary Cancer Center.David Alexander Ziegler, Cecilia Christiane Cleve, Sonia Ziegler
|Nov 17, 2023
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.Charles M Rudin, Stephen V Liu, Ross A Soo
Pageof 2
Frequent Collaborators
2 joint publications
Tobias Raphael Overbeck
2 joint publications
Stefan Andreas
2 joint publications
Alexander Freiherr von Hammerstein-Equord
2 joint publications
Moritz Weber
2 joint publications
Martin Reck
1 joint publications
Charles M Rudin
1 joint publications
Stephen V Liu
1 joint publications
Shun Lu
1 joint publications
Min Hee Hong
1 joint publications
Chao-Hua Chiu
